Please login to the form below

Not currently logged in
Email:
Password:

Caelyx

This page shows the latest Caelyx news and features for those working in and with pharma, biotech and healthcare.

NICE recommends two drugs for ovarian cancer but rejects three

NICE recommends two drugs for ovarian cancer but rejects three

Paclitaxel and Caelyx given preliminary nod. NICE has recommended paclitaxel and Jansen-Cilag's Caleyx for the treatment of ovarian cancer in draft guidance. ... Both paclitaxel and Caelyx (pegylated liposomal doxorubicin hydrochloride) are recommended

Latest news

More from news
Approximately 3 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Grace Communications

Grace Communications is an award winning, independent, full service, creative communications agency specialising in solving problems for healthcare brands....

Latest intelligence

NHS regional footprints
What to expect from 2019...
Not another weight-loss ad
Christmas is over and the gyms are packed, it’s a never-ending tale. But why do we do it to ourselves every year?...
China’s clinical trial shake-up
As many of the obstacles to running clinical trials in China fall away, the country is proving to be a better research location...

Infographics